Skip to Content

SML3038

JB170

≥98% (HPLC)

Synonym(s):

4-((9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-yl)amino)-N-(2-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)ethoxy)ethoxy)ethyl)-2-methoxybenzamide, Thalidomide-PEG2-Alisertib

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C48H44ClFN8O11
CAS Number:
Molecular Weight:
963.36
UNSPSC Code:
12352107
NACRES:
NA.77
Assay:
≥98% (HPLC)
Form:
powder
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Segment

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear (Warmed)

storage temp.

2-8°C

SMILES string

O=C1N(C2CCC(NC2=O)=O)C(C3=C1C(OCC(NCCOCCOCCNC(C4=CC=C(NC5=NC(C(C=CC(Cl)=C6)=C6C(C7=C(OC)C=CC=C7F)=NC8)=C8C=N5)C=C4OC)=O)=O)=CC=C3)=O

InChI key

GYKNPXCQINZRLL-UHFFFAOYSA-N

Biochem/physiol Actions

JB170 is a highly specific AURORA-A degrader (PROTAC) comprising aurora kinase inhibitor alisertib connected to the CEREBLON-binding molecule thalidomide. JB170 induces rapid and durable degradation of AURORA-A in cancer cells leading to strong S-phase arrest and apoptosis.
highly specific AURORA-A degrader (PROTAC) that induces rapid and durable degradation of AURORA-A in cancer cells


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library